Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Thymosin α1: a single drug with multiple targets in cystic fibrosis

Nature Medicine volume 23, pages 536–538 (2017)Cite this article

Subjects

A new study in mice suggests that a single drug, thymosin α1, may simultaneously rectify the impaired trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis (CF) and reduce inflammation, offering new hope for CF treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The multiple effects of Tα1 on pathophysiological mechanisms relevant to cystic fibrosis.

Kim Caesar/Springer Nature

References

  1. Spielberg, D.R. & Clancy, J.P. Annu. Rev. Genomics Hum. Genet. 17, 155–175 (2016).

    Article  CAS  Google Scholar 

  2. Romani, L. et al. Nat. Med. 23, 590–600 (2017).

    Article  CAS  Google Scholar 

  3. Sly, P.D. et al. N. Engl. J. Med. 368, 1963–1970 (2013).

    Article  CAS  Google Scholar 

  4. Shah, V.S. et al. Science 351, 503–507 (2016).

    Article  CAS  Google Scholar 

  5. Tang, X.X. et al. J. Clin. Invest. 126, 879–891 (2016).

    Article  Google Scholar 

  6. Hisert, K.B. et al. Am. J. Respir. Crit. Care Med. http://dx.doi.org/10.1164/rccm.201609-1954OC (2017).

  7. Atlante, A. et al. J. Bioenerg. Biomembr. 48, 197–210 (2016).

    Article  CAS  Google Scholar 

  8. Carlile, G.W. et al. J. Cyst. Fibros. 14, 16–25 (2015).

    Article  CAS  Google Scholar 

  9. Iannitti, R.G. et al. Nat. Commun. 7, 10791 (2016).

    Article  CAS  Google Scholar 

  10. Maghzal, G.J., Thomas, S.R., Hunt, N.H. & Stocker, R. J. Biol. Chem. 283, 12014–12025 (2008).

    Article  CAS  Google Scholar 

  11. Iannitti, R.G. et al. Am. J. Respir. Crit. Care Med. 187, 609–620 (2013).

    Article  CAS  Google Scholar 

  12. Low, T.L. et al. J. Biol. Chem. 254, 981–986 (1979).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. André M. Cantin is in the Pulmonary Division, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.,

    André M Cantin

  2. John W. Hanrahan is in the Department of Physiology, McGill University, Montréal, Québec, Canada.,

    John W Hanrahan

Authors
  1. André M Cantin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W Hanrahan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to André M Cantin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cantin, A., Hanrahan, J. Thymosin α1: a single drug with multiple targets in cystic fibrosis. Nat Med 23, 536–538 (2017). https://doi.org/10.1038/nm.4339

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4339

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing